Latest posts
-
SKYX Platforms (SKYX) Increases Patent Count With Five Additional Issued in US and International
September 22, 2023 Today SKYX Platforms (SKYX) has announced the issuance of five new utility patents in the U.S. and international markets including Canada, Mexico and Hong Kong for its related smart plug-and-play products including a ceiling fan with a heater and recessed light. The company now has 77 issued and pending patents, globally. Recent Announcements Recently,
-
SKYX Appoints Widely-Respected Public Financial Markets Authority, Lenny Sokolow as Co-CEO
“I can’t emphasize enough how excited I am to join SKYX and introduce its growth opportunity to the financial institution segments during its inflection point. As evidence, I agreed for the majority of my compensation to be paid in SKYX’s stock and stock options.” Leonard (Lenny) Sokolow “Growth Opportunity at Key Inflection Point” HIGHLIGHTS ABOUT
-
Oncocyte’s VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”] Interventional study compares VitaGraft to current transplant rejection monitoring protocols Oncocyte’s VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than commonly used monitoring protocols (p<0.001) IRVINE, CA, September 18, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced the presentation of significant new clinical data
-
AmpliTech to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
CEO Fawad Maqbool will be meeting with registered investors on September 11-12, 2023 HAUPPAUGE, NY, September 8, 2023 – AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for
-
AmpliTech Group Announces Newly Released Passive Product Lines for RF Industry
New Passive Components Provide Exceptional Performance, Reliability, and Versatility and Complement Active LNA Product Line Additional New Product Announcements Expected by Year End 2023 HAUPPAUGE, NY, September 6, 2023 – AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of
-
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
CEO Josh Riggs will be meeting with registered investors on September 11-12, 2023 IRVINE, CA, September 6, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it will participate in the upcoming H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023, at the Lotte New York Palace Hotel. Josh
-
Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
First digital-droplet PCR assay to receive coverage Expect initial revenue generation in Q1 2024 IRVINE, CA, August 28, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that Palmetto GBA, the Medicare Administrative Contractor for the Centers for Medicare & Medicaid Services (CMS), has issued a positive coverage decision for the Company’s VitaGraft
-
AmpliTech Group Named Finalist in Prestigious HIA-LI 29th Annual Business Achievement Awards
Finalists Represent Top Contenders for Long Island-based Business Awards; Winners will be Announced during HIA-LI Annual Business Achievement Awards, Thursday, September 21, 2023 HAUPPAUGE, NY, August 23, 2023 – AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G
-
AmpliTech Reports Second Quarter 2023 Financial Results
Reports Sales of $4.1 million, $1.9 million Gross Profit, and Record Gross Margin of 47% Company Continues to Invest for Growth HAUPPAUGE, NY, August 14, 2023 – AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and
-
Oncocyte Reports Second Quarter 2023 Financial Results
Conference Call on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, August 10, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the second quarter of 2023, ended June 30, 2023. Second Quarter and Recent Highlights “In the second quarter, we made significant progress